Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03076853
Other study ID # 13-PREPS-01
Secondary ID
Status Completed
Phase N/A
First received February 27, 2017
Last updated March 6, 2017
Start date April 3, 2016
Est. completion date June 30, 2016

Study information

Verified date March 2017
Source Centre Hospitalier Universitaire de Nice
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of MATRIX-DPRS is to assess the clinical and organizational impacts of the use of the medication record, opened, filled and managed by pharmacists (from private office and hospital units) by hospital physicians in private and public healthcare establishments (volunteers), for three clinical contexts: anaesthesiology visit before surgery, medications abuse and emergency hospitalization, medications and elderly hospitalisations.


Description:

As part of the national 2012 PREPS call for proposals, a multidisciplinary research team was set up to design and develop methods in order to evaluate the efficiency and the performance of health data information systems. This team is composed of physicians and researchers in medical informatics, hospital information systems, biostatistics, process analysis and management in healthcare, ergonomics and usability. This study was aimed to evaluate the clinical and organizational impacts of the use of a new source of information brought by the pharmaceutical record, promoted by the national committee of pharmacists. This record is opened and filled for each patient by the pharmacist. It contains all the medication sold (prescribed by physician and OTC) by the patient. This record is used by almost all the private pharmacists. The French Health Ministry was looking for an evaluation of this new source of information by hospital physicians in order to be applied by any healthcare institution or organization wishing to evaluate the added value of its investments or recommendations (example: ARS (French Regional Health Agency), DGOS (French Directorate General of Health Services), etc.) in the information system.


Recruitment information / eligibility

Status Completed
Enrollment 511
Est. completion date June 30, 2016
Est. primary completion date June 30, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Concerning Anesthesia department:

- Patients in pre-anesthesia consultation for scheduled intervention.

Concerning Emergencies department:

- Patients admitted for fainting fit

Regarding patients hospitalized in geriatrics:

- Patients admitted to geriatrics

Exclusion Criteria:

- Minors

- Patients without administrative or judicial freedom if the authorization of the legal representative can not be collected.

Study Design


Related Conditions & MeSH terms

  • Patients With Pharmaceutical Record

Intervention

Other:
Opening of the Pharmaceutical Record
After a first prescription without the pharmaceutical record, the study investigator has to open the pharmaceutical record to obtain some additional data. After, he has to choose between maintain or modify his first prescription.

Locations

Country Name City State
France CHU de Nice Nice

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modification of the medical prescription linked to the use of the pharmaceutical record The primary outcome measure is to evaluate the impact of the use of the pharmaceutical record on th medical prescription. The doctor writes a first medical prescription without using the pharmaceutical record and a second with the pharmaceutical record.The changes are analyzed. 3 months